Synexus is currently conducting a research study of an investigational influenza drug.
Qualified study participants 12 years or older, who have other risk factors, will receive study-related care and the investigational drug or placebo. There is no cost for participation and qualified individuals may receive compensation for time and travel.
Cal us within 48 hours of symptoms.
do NOT contact me with unsolicited services or offers